Carbapenemases and homology of imipenem resistant Acinetobacter baumannii isolates in Xi'an

Chinese Journal of Infection and Chemotherapy

Volumn 9, Issue 1, 2009, Pages 37-41

  Liu, Yuan ^a   Tan, Xiang Shu ^a   Han, Xing Peng ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Carbapenemases; Enterobacterial repetitive intergenic consensus PCR; OXA 58

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TIMENTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHINA; CONTROLLED STUDY; DNA FINGERPRINTING; ENTEROBACTERIACEAE; GENE AMPLIFICATION; GENERAL HOSPITAL; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE;

EID: 59349112159     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ayan M, Durmaz R, Aktas E, et al. Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital [J]. J Hosp Infect, 2003, 54(1):39-45.
2. Richet HM, Mohammed J, McDonald LC, et al. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance [J]. Emerg Infect Dis,2001,7(2):319-322.
3. Walsh TR, Bolmstrom A, Qwarnstrom A, et al. Evaluation of a new E test for detecting metallo-β-lactamases in routine clinical testing [J]. J Clin Microbiol,2002,40(8):2755-2759.
4. Jeong SH, Bae IK, Pack KO, et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea [J]. J Microbiol, 2006, 44(4):423-431.
5. Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infection with imipenem- resistance Acinetobacter baumannii treated with ampicilin/ sulbactam [J]. Int J Antimicrob Agents, 2003,21 (1): 58-62.
6. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes [J]. Clin Microbiol Infect, 2002,8(6):321-331.
7. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology[J]. Clin Microbiol Infect, 2006, 12(9):826-836.
8. Quale J, Bratu S, Landman D, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City [J]. Clin Infect Dis, 2003, 15: 37(2):214-220.
9. Livermore DM, Woodford N. Carbapenemases: a problem in waiting? [J]. Curr Opin Microbiol,2000,3(5):489-495.
10. Poirel L, Marque' S, He'ritier C, et al. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii [J]. Antimicrob Agents Chemother, 2005,49(1): 202-208.
11. Naas T, Nordmann P. OXA-type-β-Lactamases [J]. Curr Pharm Des,1999,5(11):865-879.
12. Giordano A, Varesi P, Bertini A, et al. Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, Italy [J]. Microb Drug Resist, 2007, 13(1):37-43.
13. Brown S, Amyes SG. The sequences of seven class D β-lactamases isolated from carbapenem resistant Acinetobacter baumannii from four continents[i]. Clin Microbiol Infect,2005, 11 (4):326-328.
14. Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese Hospitals[J]. Antimicrob Agents Chemother, 2007,51(11): 4022-4028.